Second-line switch to dolutegravir noninferior in HIV
For patients with HIV without genotype information, a second-line switch to dolutegravir is noninferior to a regimen containing a ritonavir-boosted ...
Read moreFor patients with HIV without genotype information, a second-line switch to dolutegravir is noninferior to a regimen containing a ritonavir-boosted ...
Read moreTreatment with the chimeric antigen receptor (CAR) T-cell therapy axicabtagene ciloleucel (axi-cel; Yescarta) resulted in significantly improved overall survival compared ...
Read more© 2023 earth-news.info